🇺🇸 FDA

Company profile · Sponsor

Reddy

Reddy Holding GmbH

E82441F · EMA pharma EU
Pipeline
1
Drugs
0
Patents
0

Quick answer

Reddy (E82441F) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E82441F
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (1)

Search pipeline →

  1. ORENCIA 250 mg powder for concentrate for solution for infusion, METHOTREXATE/PFIZER, ORENCIA 250 mg powder for concentrate for solution for infusion, ORENCIA 250 mg powder for concentrate for solution for infusion, DRL_AB

    Reddy

    Rheumatoid Arthritis

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Reddy?

Reddy (E82441F) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Reddy sponsor?

We track 1 ClinicalTrials.gov-linked program for Reddy, including ORENCIA 250 mg powder for concentrate for solution for infusion, METHOTREXATE/PFIZER, ORENCIA 250 mg powder for concentrate for solution for infusion, ORENCIA 250 mg powder for concentrate for solution for infusion, DRL_AB. Open each program for phase, modality, NCT IDs, and indication details.

Where does Reddy company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.